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SCIENTIFIC OPINION  
Scientific Opinion on the safety and efficacy of Feedlyve AXC (endo-1,4-
beta-xylanase) as a feed additive for turkeys
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Feedlyve AXC is an enzyme preparation containing an endo-1,4-beta-xylanase produced by a non-genetically 
modified strain of Trichoderma koningii. The additive is intended for use in turkeys and is presented in several 
forms. A tolerance study performed with a 100-fold of the maximum recommended dose (100 AXC/kg feed) 
showed no adverse effects in turkeys for fattening. Therefore, it is concluded that Feedlyve AXC is safe for 
turkeys for fattening at the maximum recommended dose. This conclusion is extended to turkeys reared for 
breeding. The results of two genotoxicity in vitro studies and a sub-chronic oral toxicity study did not indicate 
any concern for consumer safety arising from the use of the additive in feed for turkeys. Feedlyve AXC 6000P 
was negative in dermal and eye irritation tests in the rabbit. No data on the skin/eye irritation potential of the 
BRUTE formulation is available. Therefore, the FEEDAP Panel considers it prudent to treat this formulation as a 
potential skin/eye irritant. No skin sensitization and no acute respiratory toxicity were observed in appropriate 
tests using the BRUTE formulation. Due to the proteinaceous nature of the compound the additive is to be 
considered as a potential respiratory sensitiser. The active substance of Feedlyve AXC is a protein and as such 
will be degraded/inactivated during the passage through the digestive tract of animals. Therefore, no risks for the 
environment are expected and no further environmental risk assessment is required. A total of three efficacy 
studies in turkeys for fattening were provided. Results showed that the additive has the potential to be efficacious 
when added to diets for turkeys for fattening at a minimum dose of 75 AXC/kg complete feed. This conclusion 
can be extended to turkeys reared for breeding. 
© European Food Safety Authority, 2012 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the additive 
Feedlyve AXC when used as a zootechnical additive in turkeys. This additive is a preparation of endo-
1,4-beta-xylanase (EC 3.1.2.8) produced by a non-genetically modified strain of Trichoderma koningii 
(MUCL 39203). It is intended for use in turkeys for fattening and reared for breeding at a dose range 
of 75 to 100 AXC/kg feed.  
The additive is presented in several forms, and the solid and liquid forms of the product are considered 
to be equivalent in terms of safety for the target animals and efficacy. 
A tolerance study performed with a 100-fold of the maximum recommended dose, showed no adverse 
effects in turkeys for fattening. Therefore, the FEEDAP Panel concludes that Feedlyve AXC is safe 
for turkeys for fattening at the maximum recommended dose (100 AXC/kg feed). This conclusion is 
extended to turkeys reared for breeding. 
The results of two genotoxicity in vitro studies and a sub-chronic oral toxicity study did not indicate 
any concern for consumer safety arising from the use of the additive as a feed additive for turkeys. 
Feedlyve AXC 6000P was negative in dermal and eye irritation tests in the rabbit. No data on the 
skin/eye irritation potential of the BRUTE formulation is available. Therefore, the FEEDAP Panel 
considers it prudent to treat this formulation as a potential skin/eye irritant. No skin sensitization and 
no acute respiratory toxicity were observed in appropriate tests using the BRUTE formulation. Due to 
the proteinaceous nature of the compound the additive is to be considered as a potential respiratory 
sensitiser. 
The active substance of Feedlyve AXC is a protein and as such will be degraded/inactivated during the 
passage through the digestive tract of animals. Therefore, no risks for the environment are expected 
and no further environmental risk assessment is required. 
A  total  of  three  efficacy  studies  in  turkeys  for  fattening  were  provided.  Results  showed  that  the 
additive has the potential to be efficacious in diets for turkeys for fattening at a minimum dose of 75 
AXC/kg complete feed. This conclusion can be extended to turkeys reared for breeding. Feedlyve AXC for turkeys 
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BACKGROUND  
Regulation  (EC)  No  1831/2003
4  establishes the rules governing the Community   authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7.  
The European Commission received a request from Lyven
5 for authorisation of the product Feedlyve 
AXC, endo-1,4-beta-xylanase, when used as a feed additive for  turkeys  (category:  zootechnical 
additives; functional group: digestibility enhancers) under the conditions mentioned in Table 1.  
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application to the European Food Safety Authority (EFSA) as an application under  Article 4(1) 
(authorisation of a feed addit ive or new use of a feed additive). EFSA received directly from the 
applicant  the  technical  dossier  in  support  of  this  application.
6  According  to  Article  8  of  that 
Regulation, EFSA, after verifying the particulars and documents submitted by the applicant,  shall 
undertake an assessment in order to determine whether the feed additive complies with the conditions 
laid down in Article 5. The particulars and documents in support of the application were considered 
valid by EFSA as of 19 November 2010. 
The Scientific Committee on Animal Nutrition (SCAN) issued an opinion on the safety of the product 
Feedlyve AXC for chickens for fattening ( EC, 1998, updated on 2002). The additive is authorised 
without time limit for use in chickens for fattening.
7 
 
TERMS OF REFERENCE 
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of the product 
Feedlyve AXC (endo-1,4-beta-xylanase), when used under the conditions described in Table 1. 
                                                       
4   Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5 
 Lyven, ZAC Normandial-11, avenue du Pays de Caen, Colombelles, France. 
6   EFSA Dossier reference: FAD-2008-0004. 
7 
 Commission Regulation (EC) No 828/2007 of 13 July 2007concerning the permanent and provisional authorisation of 
certain additives in feedingstuffs OJ L 184, 14.7.2007, p.12. Feedlyve AXC for turkeys 
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Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive  
Endo-1,4-beta-xylanase  produced  by  Trichoderma  koningii  (MUCL 
39203) 
Registration number/EC 
No/No (if appropriate)  EC 3.2.1.8 
Category(-ies) of additive  Zootechnical additives 
Functional group(s) of additive  Digestibility enhancers 
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
(if appropriate) 
Method of analysis 
(if appropriate) 
Endo-1,4-beta-xylanase  Protein     
 
Trade name (if appropriate)  FEEDLYVE AXC (200L; 1500L; 1500P; 6000P; BRUTE) 
Name of the holder of 
authorisation (if appropriate)  LYVEN 
 
Conditions of use 
Species  or 
category  of 
animal 
Maximum 
Age 
Minimum content  Maximum content  Withdrawal 
period 
(if appropriate)  mg/kg of complete feedingstuffs 
Turkeys  for 
fattening 
 
 
Turkeys raised for 
breeding 
No 
maximum 
 
 
30 weeks 
75 AXC units/kg  100 AXC units/kg   
 
Other provisions and additional requirements for the labeling 
Specific conditions or restrictions for 
use (if appropriate)   
Specific conditions or restrictions for 
handling (if appropriate)  Use P3 type of mask 
Post-market monitoring  
(if appropriate)   
Specific conditions for use in 
complementary feedingstuffs  
(if appropriate) 
 
 
Maximum Residue Limit (MRL) (if appropriate) 
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
       Feedlyve AXC for turkeys 
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ASSESSMENT 
1.  Introduction 
The  additive  Feedlyve  AXC  is  a  preparation  of  endo-1,4-beta-xylanase  (EC  3.1.2.8;  xylanase) 
produced by a non-genetically modified strain of Trichoderma koningii (MUCL 39203).
8 This additive 
is authorised for use in chickens for fattening (E 1641, solid form 1500P and liquid form 200L). The 
applicant is asking for its authorisation as a feed additive for turkeys for fattening and reared for laying 
and it is proposed to be classified as a zootechnical additive under the functional group of digestibility 
enhancers. 
2.  Characterisation 
The applicant describes four formulations of the additive, two solid (Feedlyve AXC 1500P and 6000P) 
and  two  liquid  (Feedlyve  AXC  (200L  and  1500L))  as  well  as  a  non-standardised  formulation 
(Feedlyve AXC BRUTE).  
The solid formulations Feedlyve AXC 1500P and Feedlyve AXC 6000P contain 7.5 to 10 % or 30 to 
40 %, respectively, of spray-dried enzyme concentrate, feed grade tricalcium phosphate (~ 2 %) and 
oven-dried  wheat  flour  (up  to  100 %)  ensuring  a  minimum  of  1 500  and  6 000  xylanase  units/g, 
respectively. One xylanase unit (AXC) is the quantity of enzyme which liberates 17.2  moles of 
reducing  sugars  (maltose  equivalents)  per  minute  from  oat  xylan  at  pH  4.7  and  30 
o C.  The 
confirmation of the minimum activity was provided for five batches of each formulation (1 856 ± 259 
and 7 071 ± 754 AXC/g for the 1500 and 6000P, respectively).
9  
These solid formulations are light -brown powder forms and the particle size analysis revealed that 
32 % in the Feedlyve AXC 1500P and 37 % in the Feedlyve AXC 6000P are below 50 µm, less than 
2 % is below 10 µm.
10 Dusting potential from a 50 g sample (Stauber Heubach test) was 0.6 and 55 
mg, respectively.
11   
The liquid formulations, Feedlyve AXC 200L and Feedlyve AXC 1500L contain 1 to 10 % of enzyme 
concentrate  and  feed  grade  sorbitol  (~ 30 %),  monopotassic  phosphate  (~5 %),  potassium  sorbate 
(~ 0.02 %) and water (up to 100 %) and ensure a minimum of 200 and 1 500 AXC/g, respectively. The 
confirmation of the minimum activity was provided for five batches of each formulation (249 ± 4.3 
and 1 564 ± 146 AXC/g for the 200 and 1500L, respectively).
12 Both formulations are yellow to brown 
liquids with a density ranging from 1.15–1.23 g/mL and show a viscosity of 3 to 5.5 and 7 to 11 (cSt), 
respectively.
13  
The applicant also describes the Feedlyve AXC BRUTE form, a non-standardised formulation which 
according to the applicant shows between 15  000 and 20 000 AXC/g. This formulation is prepared 
with the spray-dried concentrate of the enzyme, arabic gum and monopotassic phosphate and is to be 
used  in  the  production  of  diluted  enzyme  preparations.  Three  batches  of  this  concentrated  form 
showed  enzyme  recoveries  between  12 500  and  21 269  AXC/g).
14  Dusting potential from a 50 g 
sample (Stauber Heubach test) was 67 mg.
15 
Three batches of Feedlyve  AXC BRUTE were analysed for impurities (total coliforms, Salmonella, 
Escherichia coli, staphylococci, sulphite reducing clostridia, heavy metals, mycotoxins) and antibiotic 
                                                       
8  Formerly classified as Trichoderma longibrachiatum. 
9  Technical dossier/ Supplementary information October 2011/Annex II.1.3.bis. 
10   Technical dossier/Supplementary information October 2011/Annex II.1.5.D.bis. 
11   Technical dossier/Supplementary information October 2011/Annex II.1.5.C. 
12   Technical dossier/ Supplementary information October 2011/Annex II.1.3.bis. 
13   Technical dossier/Section II/Annex II.1.5.B. 
14   Technical dossier/Section II/Annex II.1.4.A-C. 
15   Technical dossier/Supplementary information October 2011/Annex II.1.5.C. Feedlyve AXC for turkeys 
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activity  (two  batches).  All  values  showed  either  the  absence  of  the  contaminant  or  were  within 
acceptable limits.
16 All the materials used in the production of the additive are feed grade.  
2.1.  Stability and homogeneity 
2.1.1.  Stability of Feedlyve AXC solid formulations 
The shelf-life of Feedlyve AXC 1500P, 6000P and BRUTE (three batches for each formulation) was 
evaluated during storage in air tight packages at 4, 20 and 30 ºC up to 12 months.
17 Results showed 
that for all storage temperatures > 95 % of the initial activity was recovered compared to a frozen 
sample. Additional data showed no significant loss of the enzyme activity due to the effect of light, 
storage in open packages, and storage in open packages at a very low humidity (10 to 15 %).
18  
The stability of the xylanase from Feedlyve AXC 1500P and 60 00P to pelleting
19 was tested  in a 
wheat/soya based feed when supplemented at 100 AXC/kg. Residual activity was 33 % at 75 ºC and 
9.5 % at 80 ºC. A similar study showed no loss of activity when the feed was pelleted at 60 ºC.
20 The 
applicant recommends that the temperature during the pelleting procedure should not exceed 60 ºC. 
Subsequent storage up to three months of the pelleted feed did not result in losses of enzyme activity.  
The storage stability of Feedlyve AXC 1500P and 6000P (three batches each formu lation) was 
evaluated in a complete premixture kept at three different temperatures (4, 20 and 30  ºC) up to four 
months.
21 Recoveries after four months were at least 93 %. 
Xylanase  activity  of  Feedlyve  AXC  1500P  and  6000P  when  supplemented  in  the  range  of  the 
recommended doses to a feed based on wheat and soybean meal was measured in samples kept at 
three temperatures (4, 20 and 30 ºC) for three months. Recovery was > 96 %.
22 
2.1.2.  Stability of Feedlyve AXC liquid formulations 
The shelf-life of Feedlyve AXC 200L and 1500L (three batches for each formulation) was evaluated 
during storage in air tight packages at 4, 20 and 30 ºC up to three months.
23 Results showed no loss of 
the initial activity at 4 ºC, recoveries > 87 % at 20 ºC and > 70 % at 30 ºC. 
Additional data were provided on the effect of light and storage in open packages at 20 ºC  for three 
months and showed no significant losses (recoveries ~ 90 %).
24 
Xylanase activity of Feedlyve AXC 200L and 1500L ( three batches) when sprayed onto a pelleted 
feed (based on wheat and soya-bean meal) in the range of the recommended doses  was measured in 
samples kept at three temperatures (4, 20 and 30 ºC) for three months. Recoveries  after three months 
were > 93 %.
25 The applicant recommends that the  temperature of the pellets should not exceed 60 
ºC.
26 
2.1.3.  Homogeneity 
The capacity of homogeneous distribution of Feedlyve AXC 1500P and 6000P (three batches each) 
was studied when added at 25 AXC/g to a complete premixture.
27 A total of five samples per batch 
                                                       
16   Technical dossier/Section II/Annexes II.1.4.A-D. 
17   Technical dossier/Section II/Annex II.3.1.A. 
18   Technical dossier/Section II/Annex II.3.1.B, C and D. 
19   Technical dossier/Section II/Annex II.3.1.H. 
20   Technical dossier/Supplementary information October 2011/Annexes II.3.1.L, M and N. 
21   Technical dossier/Section II/Annex II.3.1.J and supplementary information October 2011/Annex II.3.1.J. 
22   Technical dossier/Section II/Annex II.3.1.K. 
23   Technical dossier/Section II/Annex II.3.1.A. 
24   Technical dossier/Section II/Annex II.3.1.B and C. 
25   Technical dossier/Section II/Annex II.3.1.K and supplementary information October 2011/Annex II.3.1.J. 
26   Technical dossier/Section II/Annex II.3.1.G. 
27   Technical dossier/Section II/Annex II.3.2.A. Feedlyve AXC for turkeys 
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were analysed and enzyme recoveries were close to 25 AXC/g and the coefficient of variation (CV) 
obtained was 3.2 to 5.2 % for Feedlyve AXC 1500P formulation and 4.0 to 4.9 % for Feedlyve AXC 
6000P.  
The capacity of homogeneous distribution of Feedlyve AXC 1500P and 6000P (three batches each) 
when  mixed  in  feed  based  on  wheat  and  soya-bean  meal  was  tested  when  supplemented  at  the 
recommended  dosage  (100  AXC/kg).
28  A total of  five  samples per batch were analysed , enzyme 
recoveries were close to 100 AXC/kg and the CV was 6.5 to 9.4 % for Feedlyve AXC 1500P and 5.5 
to 6.8 % for Feedlyve AXC 6000P. 
The capacity of homogeneous distribution of Feedlyve AXC 200L and 1500L (three batches each) was 
studied when added to a pelleted feed based on wheat and soya-bean meal.
29 A total of five samples 
per batch were analysed and the CV obtained ranged 6.3-10.8 % (~ 100 AXC/kg).  
2.2.  Conditions of use  
Feedlyve AXC is intended to be used as feed additive for turkeys for fattening and turkeys reared for 
breeding at a minimum dose of 75 AXC/kg complete feed and at maximum dose of 100 AXC/kg 
complete feed.  
2.3.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of the active 
substance in animal feed. The Executive Summary of the EURL report can be found in the appendix. 
3.  Safety 
3.1.  Safety for turkeys    
A total of 312 one-day-old male BUT T9 turkeys were distributed in groups of 26 birds to three 
dietary treatments (four replicates/pens per treatment).
30 The basal diet based on wheat and soya-bean 
was supplemented with Feedly ve AXC to provide 0,  100 (1X)  and 10 000  (100X)  AXC/kg  feed 
(confirmed by analysis). Birds were under study for 42 days. Feed intake was measured per pen and 
the animals were weighed individually at the end of the starter period (22 days) and at the end of 
experiment. The health status of the animals was monitored daily. Results were subject to an analysis 
of variance and Tukey’s test was performed to compare the means.  
No adverse effects were observed in mortality or performance with the supplementation with Feedlyve 
AXC at 100-fold of the maximum recommended dose (final weight ~ 2.85 kg, feed to gain ratio 1.45 
g/g). 
The FEEDAP Panel concludes that Feedlyve AXC is safe for turkeys for fattening at the maximum 
recommended dose. This conclusion is extended to turkeys reared for breeding. 
3.2.  Safety for the consumer  
Two mutagenicity/clastogenicity studies in vitro and a sub-chronic oral toxicity study in rats were 
performed using Feedlyve AXC BRUTE as the test item.  
 
                                                       
28   Technical dossier/Section II/Annex II.3.2.B. 
29   Technical dossier/Section II/Annex II.3.2.C. 
30   Technical dossier/Supplementary information October 2011/Annex. IV.1.bis and Supplementary information March 
2012/Annex IV.1.a. Feedlyve AXC for turkeys 
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3.2.1.  Genotoxicity studies including mutagenicity  
Bacterial reverse mutation assay 
One batch of the enzyme preparation Feedlyve AXC  BRUTE (12 500 AXC/g) was examined for 
mutagenic activity in Salmonella Typhimurium strains TA1535, TA1537, TA98, TA100 and TA102, 
in the presence and absence of metabolic activation (Aroclor 1254 induced S9-mix) according to 
OECD guideline 471.
31 The strains were exposed to the test material both in a direct plate and a pre -
incubation method. Five different doses were applied and the maximum was 5 mg/plate or mL.  
The test material did not induce  gene mutations in any bacterial strain, while appropriate positive 
controls gave the expected response. 
Chromosome aberration assay 
Feedlyve AXC BRUTE (12 500 AXC/g) was tested in a in vitro chromosome aberration assay in 
cultured  human  lymphocytes,  according  to  OECD  guideline  473.
32  The cells were harvested for 
analysis 24 hours after start of exposure; six doses were used, the maximum being 5 mg/mL, with and 
without metabolic activation (Aroclor 1254 induced S9-mix).  
No increase in number of aberrant cells over the untreated control was observed in any experimental 
condition. Positive controls showed significant effects.  
3.2.2.  Sub-chronic oral toxicity study 
The systemic toxic potential of Feedlyve AXC BRUTE (18 600 AXC/g), to rats by oral administration 
was assessed over a period of 13 weeks, in compliance with OECD guideline 408.
33 In addition to a 
control group, three groups, each comprising ten male and ten female Sprague Dawley rats, received 
the test material through the diet at 0.25, 0.75 and 2 % (up to 26 100 AXC/kg bw for males and 32270 
AXC/kg bw for females). During the study, clinical condition, bodyweight, food consumption, water 
consumption,  ophthalmoscopy,  haematology,  blood  chemistry,  organ  weight,  gross-  and 
histopathology (control and high dose only) investigations were undertaken.  
Minor changes in haematology and blood chemistry were reported, but these were not indicative of 
toxicity.  In  addition,  no  relevant  findings  were  observed  in  organ  weight  and  gross-  and 
histopathology.  
3.2.3.  Conclusions on the safety for the consumer 
The results of two genotoxicity in vitro studies and a sub-chronic oral toxicity study did not indicate 
any concern for consumer safety arising from the use of the Feedlyve AXC as a feed additive for 
turkeys. 
3.3.  Safety for the user  
3.3.1.  Skin and eye irritation tests 
The test item used in these studies was Feedlyve AXC 6000P. 
The eye irritating potential of the additive was assayed in an experiment with three young adult male 
albino rabbits (New Zealand White), according to OECD guideline 405.
34 Each animal was treated 
with a single ocular instillation of 100  mg of the test material. Individual eye irritation scores were 
                                                       
31   Technical dossier/Section IV/Annex IV.2.1.A. 
32   Technical dossier/Section IV/Annex IV.2.1.B. 
33   Technical dossier/Section IV/Annex IV.2.2.A to D. 
34   Technical dossier/Section IV/Annex IV 3.1.1. Feedlyve AXC for turkeys 
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recorded at 1, 24, 48 and 72 hours after treatment. Signs of ocular irritation were observed over a 
limited period of time; within 24 hours the symptoms had disappeared and thus the test item is not to 
be classified as eye irritant according to the EC standards. 
An acute dermal irritation study according to OECD guideline 404 was performed in six male rabbits 
(New Zealand White) with 500 mg of the additive.
35 The test item was applied for four hours and signs 
of cutaneous reactions were observed 1, 24, 48 and 72 hours after the withdrawal of the application. 
Minimal erythema with dryness and no oedema was noticed up to 72 h ours, and the mean score did 
not warrant classification as skin irritant.  
3.3.2.  Skin sensitisation test 
Skin sensitisation potential was tested in female Guinea pigs according to the Magnusson/Kligman 
maximisation method (OECD guideline 406) with Feedlyve AXC BRUTE.
36 After dermal induction 
all animals (including the controls) were challenged 22 and 33 days afterwards with the test substance 
on the skin. In both groups erythema and  oedema were noticed after challeng e (3/4 controls, 2/10 
treated), but as it occurred also in the controls, and occurred to a lesser degree in the second challenge 
(where a less concentrated form was applied), it is concluded that this reaction was due to the transient 
irritant properties and not to sensitisation.  
3.3.3.  Effects on respiratory system 
Five SD rats of either sex were exposed to Feedlyve AXC BRUTE at 5 mg/L in air for 4 hours (OECD 
guideline 403).
37 Exposed animals displayed exaggerated respiration immediately post exposure. No 
mortality occurred and at necropsy no treatment related findings were noticed. 
3.3.4.  Systemic toxicity 
The systemic hazard is very limited as concluded under consumer safety. In addition, exposure of 
users is not expected to be significant.   
3.3.5.  Conclusions on the safety for the user 
Feedlyve AXC 6000P was negative in dermal and eye irritation tests in the rabbit. No data on the 
skin/eye irritation potential of the BRUTE formulation was made available. Therefore, the FEEDAP 
Panel considers it prudent to treat this formulation as a potential skin/eye irritant.  
No skin sensitization and no acute respiratory toxicity were observed in appropriate tests using the 
BRUTE formulation. Due to the proteinaceous nature of the active substance the additive is to be 
considered as a potential respiratory sensitiser. 
3.4.  Safety for the environment 
The active substance of Feedlyve AXC is a protein and as such will be degraded/inactivated during the 
passage through the digestive tract of animals. Therefore, no risks for the environment are expected 
and no further environmental risk assessment is required. 
4.  Efficacy  
A total of three floor-pen experiments were performed to provide evidence of efficacy in turkeys for 
fattening.  
In the three trials one-day-old turkeys (BUT T9), males in trial 1 and females in trials 2 and 3, were 
distributed  to  two  dietary  treatments.  Basal  diets  based  on  wheat  and  soya-bean  meal  were 
supplemented with xylanase to provide 0 and 75 AXC/kg in trial 1 and 0 and 125 AXC/kg complete 
                                                       
35   Technical dossier/Section IV/Annex IV 3.1.2. 
36   Technical dossier/Section IV/Annex IV.3.2. 
37   Technical dossier/Section IV/Annex IV.3.3. Feedlyve AXC for turkeys 
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feed in trials 2 and 3.
38 In all trials, a solid form of the additive was used  and diets were  pelleted 
(pelleting temperature 85 ºC in trial 1 and 65 ºC in trials 2 and 3).
39 Enzyme activities were confirmed 
in trial 1, in trials 2 and 3 the analysed values were below the intended dose.  Body weight and feed 
intake were measured and feed to gain ratio was calculated. The health status of the animals was 
monitored daily. 
The main characteristics of the trials can be found in Table 2 and the results in Table 3. 
Table 2:   Design of the performance experiments in turkeys  
Trial 
  
Breed 
Duration 
(days) 
Sex 
Total No Animals 
(animals/replicate) 
replicates/treatment 
Intended enzyme 
supplementation 
(AXC/kg) 
Analysed 
enzyme activity 
(AXC/kg) 
1
40 
BUT 9 
118 
♂ 
400 
25 
8 
0 
75 
- 
72-82 
2
41 
BUT 9 
84 
♀ 
372 
31 (25)
1 
6 
0 
125 
- 
55-82 
3
42 
BUT 9 
84 
♀ 
372 
31 (25)
1 
6 
0 
125 
- 
68-81 
  1 On the sixth week of study the 3 heavier and 3 lighter animals were removed from each pen. 
Table 3:   Effect of Feedlylve AXC in the performance of turkeys for fattening 
Trial  Intended dosage 
(AXC/kg) 
Feed intake 
(g/d) 
Final weight 
(g) 
Feed to gain 
ratio 
Mortality 
(%) 
1  0 
75 
275 
277 
13 101 
13 301 
2.51
a 
2.47
b 
2.1 
6.6 
2  0 
125 
195
a 
189
b 
7 843 
7 770 
2.09
a 
2.04
b 
4.8 
4.8 
3  0 
125 
190 
190 
7 707 
7 954 
2.09
a 
2.02
b 
1.1 
1.1 
a, b: Means with different superscripts in the same column within one trial are significantly different (P<0.05) 
No significant differences were observed in mortality between treatments. Feed to gain ratio was 
significantly improved in the three trials by the addition of Feedlyve AXC at 75 AXC/kg complete 
feed (analysed values). Therefore, the FEEDAP Panel concludes that the additive has the potential to 
be  efficacious  when  added  to  diets  for  turkeys  for  fattening  at  a  minimum  dose  of  75  AXC/kg 
complete feed. This conclusion can be extended to turkeys reared for breeding. 
5.  Post-market monitoring  
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
43  and  Good 
Manufacturing Practice. 
                                                       
38   Five basal diets in trial 1 and three basal diets in trials 2 and 3 according to the requirements. 
39   In trial 1, diets provided as crumbs until day 35 and in trials 2 and 3 as mash during the first two weeks. 
40   Technical dossier/Section III/Annex III.2.A. 
41   Technical dossier/Section III/Annex III.2.B and Supplementary information March 2012. 
42   Technical dossier/Section III/Annex III.2.C and Supplementary information March 2012. 
43   Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down 
requirements for feed hygiene. OJ L 35, 8.2.2005, p. 1. Feedlyve AXC for turkeys 
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CONCLUSIONS 
The solid and liquid forms of the product are considered to be equivalent in terms of safety for the 
target animals and efficacy. 
Based on a tolerance study in which no adverse effects were observed in turkeys for fattening, the 
FEEDAP  Panel  concludes  that  Feedlyve  AXC  is  safe  for  the  target  species  at  the  maximum 
recommended dose (100 AXC/kg). This conclusion is extended to turkeys reared for breeding. 
The results of two genotoxicity in vitro studies and a sub-chronic oral toxicity did not indicate any 
concern for consumer safety arising from the use of Feedlyve AXC as a feed additive for turkeys. 
Feedlyve AXC 6000P was negative in dermal and eye irritation tests in the rabbit. No data on the 
skin/eye irritation potential of the BRUTE formulation is available. Therefore, the FEEDAP Panel 
considers it prudent to treat this formulation as a potential skin/eye irritant. No skin sensitization and 
no acute respiratory toxicity were observed in appropriate tests using the BRUTE formulation. Due to 
the proteinaceous nature of the compound the additive is to be considered as a potential respiratory 
sensitiser. 
The active substance of Feedlyve AXC is a protein and as such will be degraded/inactivated during the 
passage through the digestive tract of animals. Therefore, no risks for the environment are expected 
and no further environmental risk assessment is required. 
The additive has the potential to be efficacious when added to diets for turkeys for fattening at a 
minimum dose of 75 AXC/kg complete feed. This conclusion can be extended to turkeys reared for 
breeding. 
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APPENDIX 
In  the  current  application  authorisation  is  sought  under  article  4(1)  for  Feedlyve  AXC,  under  the 
category/functional group 4(a) "zootechnical additives" / "digestibility enhancers", according to the 
classification system of Annex I of Regulation (EC) No 1831/2003. According to the Applicant, the 
feed additive contains endo-1,4- -xylanase (EC 3.2.1.8) as the active agent, produced by the strain 
Trichoderma  koningii  (MUCL  39203).  The  additive  is  intended  to  be  marketed  as  several 
formulations:  
  liquid Feedlyve AXC 200L
 and Feedlyve AXC 1500L, with a guaranteed minimum endo-1,4- -
xylanase activity of 200 and 1500 AXC/mL, respectively; and 
  solid/powder Feedlyve AXC 400P, Feedlyve AXC 1500P, Feedlyve AXC 6000P and Feedlyve 
AXC 12000P, with a guaranteed minimum endo-1,4- -xylanase activity of 400, 1500, 6000 
and 12000 AXC/g, respectively.  
The activity of endo-1,4- -xylanase is expressed in xylanase units (AXC). According to the Applicant, 
one AXC unit is the quantity of enzyme which liberates 17.2  moles of reducing sugars (maltose 
equivalents) per minute from oat xylan at pH 4.7 and 30 
oC.  
Specifically, authorisation is sought for the use of Feedlyve AXC for turkeys for fattening. The feed 
additive is intended to be used in premixtures and/or complete feedingstuffs, with a minimum endo-
1,4- -xylanase activity in complete feedingstuffs of 75 AXC/kg. 
For the quantification of endo-1,4- -xylanase in the feed additive and feedingstuffs, the Applicant 
submitted similar single-laboratory validated and further verified colorimetric methods, based on the 
enzymatic hydrolysis of oat spelt xylan at pH 4.7 and 30 °C and the quantification of dyed oligomers 
released  from  the  substrate  Remazol-Brilliant-Blue-R  xylan.  The  following  performance 
characteristics were reported: - a relative standard deviation for repeatability (RSDr) ranging from 1.3 
to 14 %; - a relative standard deviation for intermediate precision (RSDip) ranging from 5.2 to 14 %; – 
a recovery rate (RRec) ranging from 91 to 115 % and a limit of quantification (LOQ) of 35 AXC/kg 
feedingstuffs. 
No experimental data were submitted by the Applicant for the determination of endo-1,4- -xylanase in 
premixtures. However, premixture samples could be diluted with blank feedingstuffs material (such as 
heat-treated wheat flour) and analysed as feedingstuffs using the method mentioned above.  
Based on the performance characteristics presented, the EURL recommends for official control the 
single-laboratory  validated  and  further  verified  colorimetric  methods  based  on  the  enzymatic 
hydrolysis of oat spelt xylan at pH 4.7 and 30 °C and the quantification of dyed oligomers released 
from  the  substrate  Remazol-Brilliant-Blue-R  xylan  to  determine  the  endo-1,4- -xylanase  in  feed 
additive, premixtures and feedingstuffs, within the concentration range covered by the experimental 
data.  
Further  testing  or  validation  of  the  methods to  be performed  through  the consortium  of  National 
Reference Laboratories as specified by article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 